Ticker Details
Sight Sciences, Inc. Common Stock
IPO Date:	July 12, 2021
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$273.68M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.30 | 3.59%
Avg Daily Range (30 D):	$0.18 | 4.10%
Avg Daily Range (90 D):	$0.16 | 3.31%

Institutional Daily Volume
Avg Daily Volume:	.21M
Avg Daily Volume (30 D):	.25M
Avg Daily Volume (90 D):	.26M

Trade Size
Avg Trade Size (Sh.):	81
Avg Trade Size (Sh.) (30 D):	74
Avg Trade Size (Sh.) (90 D):	72

Institutional Trades
Total Institutional Trades:	131
Avg Institutional Trade:	$2.3M
Avg Institutional Trade (30 D):	$3.75M
Avg Institutional Trade (90 D):	$2.4M
Avg Institutional Trade Volume:	.2M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.3M
Avg Closing Trade (30 D):	$1.02M
Avg Closing Trade (90 D):	$1.06M
Avg Closing Volume:	259.54K

News

Sep 9, 2025 @ 3:39 PM UnitedHealthcare Adds Sight Sciences OMNI System T... Source: Vandana Singh

Jul 30, 2025 @ 11:00 AM Sight Sciences Announces the Results of a Cost-Uti... Source: Nathan Lighthizer Et Al.

Jul 29, 2025 @ 11:00 AM Sight Sciences Announces the Publication of the 24... Source: Sight Sciences, Inc.

Feb 10, 2025 @ 3:00 PM Dry Eye Treatment Devices Market Poised to Attain ... Source: Astute Analytica

Jul 18, 2024 @ 8:06 PM Sight Sciences to Report Second Quarter Financial ... Source: N/A

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.71	$-.24	$-.08
Diluted EPS	$-.71	$-.24	$-.08
Revenue	$79.55M	$19.7M	$20.39M
Gross Profit	$68.55M	$16.98M	$17.79M
Net Income / Loss	$-37.25M	$-12.98M	$-4.16M
Operating Income / Loss	$-35.65M	$-12.41M	$-3.67M
Cost of Revenue	$11M	$2.72M	$2.6M
Net Cash Flow	$-35.13M	$-7M	$-.41M
PE Ratio